* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Contact: Aimee Webster - Depression and Bipolar Support Alliance
Mental status examination wikipedia , lookup
Emergency psychiatry wikipedia , lookup
Political abuse of psychiatry wikipedia , lookup
Anti-psychiatry wikipedia , lookup
Moral treatment wikipedia , lookup
History of psychiatric institutions wikipedia , lookup
Mental disorder wikipedia , lookup
Narcissistic personality disorder wikipedia , lookup
Dissociative identity disorder wikipedia , lookup
Schizoaffective disorder wikipedia , lookup
Spectrum disorder wikipedia , lookup
Abnormal psychology wikipedia , lookup
Diagnostic and Statistical Manual of Mental Disorders wikipedia , lookup
Critical Psychiatry Network wikipedia , lookup
Postpartum depression wikipedia , lookup
Death of Dan Markingson wikipedia , lookup
Biology of depression wikipedia , lookup
Behavioral theories of depression wikipedia , lookup
Classification of mental disorders wikipedia , lookup
Major depressive disorder wikipedia , lookup
Child psychopathology wikipedia , lookup
Bipolar disorder wikipedia , lookup
History of mental disorders wikipedia , lookup
Evolutionary approaches to depression wikipedia , lookup
Controversy surrounding psychiatry wikipedia , lookup
Bipolar II disorder wikipedia , lookup
History of psychiatry wikipedia , lookup
Contact: Cindy Specht (312) 988-1163 [email protected] ## FOR IMMEDIATE RELEASE ## Depression and Bipolar Support Alliance (DBSA) Honors Top Researchers with Gerald L. Klerman Awards (CHICAGO, May 17, 2015) — The Depression and Bipolar Support Alliance (DBSA), the nation’s largest patient-run organization focusing on depression and bipolar disorder, presented its prestigious Klerman Awards to Paul E. Croarkin, D.O., M.S., Mark A. Frye, M.D., and Andrew A. Nierenberg, M.D., on Sunday, May 17, in Toronto, Ontario. Named after Gerald L. Klerman, M.D., a pivotal figure in psychiatry, these awards are the highest honors that DBSA extends to members of the scientific community. Presented annually, they recognize researchers whose work contributes to understanding the causes, diagnosis, and treatment of depression and bipolar disorder. The 2014 Gerald L. Klerman Young Investigator Award recipient is Paul E. Croarkin, D.O., M.S. Dr. Croarkin is Assistant Professor of Psychiatry at the Mayo Clinic College of Medicine and a Consultant at the Department of Psychiatry and Psychology at the Mayo Clinic in Rochester Minnesota. Dr. Croarkin’s clinical interest is understanding the neurobiology, optimal treatment, and classification of mood disorders in children and adolescents. His research focuses on understanding the pathophysiology of mood disorders and developing more effective treatments that will enhance individual outcomes and impact a considerable societal burden. A central theme among Dr. Croarkin's research is investigating the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments. Dr. Croarkin received his masters in Clinical Science from UT Southwestern Medical Center, Dallas, Texas and his Doctor of Osteopathic Medicine from University of North Texas, Fort Worth, Texas. For their career-long contributions to mental health research, the 2014 Gerald L. Klerman Senior Investigator Award recipients are Mark A. Frye, M.D., and Andrew A. Nierenberg, M.D. Dr. Frye is a Professor of Psychiatry and Director of the Mayo Clinic Depression Center. His clinical interests are in bipolar disorder, treatment resistant depression, and alcoholism with a research focus on genomics, brain imaging, and clinical trials. He received his medical degree from the University of Minnesota and completed his training at the UCLA Neuropsychiatric Institute. He completed a research fellowship in the Biological Psychiatry Branch at the National Institute of Mental Health (NIMH) in Bethesda, Maryland. He was awarded The International Society for Bipolar Disorder Mogens Schou Award for Education, 2011; the DBSA Gerald Klerman Young Investigator Award, 2003; and listed among the Best Doctors in America, 2007 – 2013. Dr. Frye has published over 200 peer-reviewed journal articles with fellow colleagues in his field. We’ve been there. We can help. 55 E. Jackson Blvd, Suite 490 ● Chicago, IL 60604 (312) 642-0049 ● Toll-Free (800) 826-3632 ● Fax (312) 642-7243 ● www.DBSAlliance.org Dr. Nierenberg is the Thomas P., Hackett, MD, Endowed Chair in Psychiatry, Director of the Bipolar Research Program, and Associate Director of the Depression Clinical and Research Program, at Massachusetts General Hospital (MGH). He is also the Director of Training and Education for the MGH Research Institute. His academic appointment is Professor of Psychiatry at Harvard Medical School. His primary clinical interests are treatment resistant depression, bipolar depression, and the longitudinal course of mood disorders. Dr. Nierenberg has over 25 years of experience in conducting clinical trials in mood disorders. He has directed the NIMH Bipolar Trials Network, was principal investigator for the multi-site Lithium Moderate Dose Study on the comparative effectiveness of lithium with other medications, Bipolar CHOICE that compared lithium and quetiapine, and the Mood Patient Powered Research Network (www.moodnetwork.org) that will gather together 50,000 patients for prospective comparative effectiveness studies. His major research interests include pharmacologic treatment and course of treatment resistant depression; bipolar depression; phenomenology, longitudinal course, and treatment of mood disorders; and the management of antidepressant-associated adverse events. He attended the Albert Einstein College of Medicine of Yeshiva University followed by a residency in psychiatry at New York University/Bellevue Hospital and then he was a Robert Wood Johnson Clinical Scholar at Yale. He has published over 400 papers and has been listed among the Best Doctors in North America for the treatment of mood and anxiety disorders continuously since 1994. He has received the National Depression and Manic Depression Association (NDMDA) Gerald L. Klerman Young Investigator Award in 2000 and the Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research in 2014. Dr. Nierenberg was listed among the World’s Most Influential Scientific Minds 2014 by Thompson Reuters for being in the top 1% of literature citations in psychiatry or psychology worldwide. In 2015, he received the Mentorship Award for exceptional mentorship in the research arena at MGH. Dr. Nierenberg lectures nationally and internationally, teaches and supervises clinicians and researchers, maintains an active clinical practice, conducts clinical trials, and serves on the editorial boards of multiple psychiatric journals. The DBSA Klerman Awards’ namesake, Gerald L. Klerman, M.D., was professor and associate chairman of research at Cornell University Hospital Medical College and one of DBSA’s earliest supporters. He conducted the first clinical trial showing the efficacy of medication and psychotherapy in preventing recurrent depression. For that trial, he developed interpersonal psychotherapy, an evidence-based treatment widely used today and modified for the adjunctive treatment of patients with bipolar disorder who are undergoing pharmacotherapy. Additionally, Dr. Klerman led the first large-scale, multisite study to understand the diagnosis, course, and genetics of major depression. Still ongoing, the study has provided critical findings on the nature of depressive disorder. ### We’ve been there. We can help. 55 E. Jackson Blvd, Suite 490 ● Chicago, IL 60604 (312) 642-0049 ● Toll-Free (800) 826-3632 ● Fax (312) 642-7243 ● www.DBSAlliance.org The Depression and Bipolar Support Alliance (DBSA) is the leading patient-directed national organization focusing on depression and bipolar disorder. DBSA’s mission is to improve the lives of people living with mood disorders. The organization fosters an environment of understanding about the impact and management of these life-threatening illnesses by providing up-to-date, scientifically-based tools and information. DBSA supports research to promote more timely diagnosis, develop more effective and tolerable treatments, and discover a cure. The organization works to ensure that people living with mood disorders are treated equitably. Assisted by a scientific advisory board comprised of the leading researchers and clinicians in the field of mood disorders, DBSA has more than 700 peer-run support groups across the country. DBSA assists millions of people each year with in-person and online peer support; current, readily understandable information about depression and bipolar disorder; and empowering tools focused on an integrated approach to wellness. For more information about DBSA or depression and bipolar disorder, please visit www.DBSAlliance.org or call (800) 826-3632. We’ve been there. We can help. 55 E. Jackson Blvd, Suite 490 ● Chicago, IL 60604 (312) 642-0049 ● Toll-Free (800) 826-3632 ● Fax (312) 642-7243 ● www.DBSAlliance.org